Mablink Bioscience
Series ALyon, FranceOct 2022
Mablink Bioscience raised €31M in a Series A round in Oct 2022. The company is based in Lyon, France. Investors in the round: Crédit Agricole Création, Elaia Partners, Fondation Fournier-Majoie and 5 others. Data as of Nov 2026.
Amount raised
€31M
€31,000,000
Native amount
31,000,000 EUR
Stage
Series A
series a
Investors
8
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €31M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
8 namedCrédit Agricole CréationElaia PartnersFondation Fournier-MajoieMérieux Equity PartnersSham Innovation SantéSimba SantéSofinnova PartnersUI-Investissement / Pertinence Invest 2
Date
Oct 2022
Round type
series a
Amount (EUR)
€31M
Other rounds
same companyRelated news
- Mablink Bioscience secures €31M to develop better treatment for cancer patientstechfundingnews.com · 2022-10